Shockwave Medical

It's time to lead the charge. #ShockwaveJavelin modifies occlusive calcium, allowing you to cross and deliver further treatment. See how the next wave of #ShockwaveIVL innovation helps you move forward: https://lnkd.in/gr4Z-TjR US Rx only. Important Safety Information: http://bit.ly/3iEq7fC

International Physicians: Don't miss the new insights on #ShockwaveReducer at #TCT2025! See all the sessions in store at TCT starting Saturday. We’re excited for the new data from the REDUCER I Observational Study at TCT Conference in which Dr. Stefan Verheye, MD, PhD will present: “Sex-Specific Outcomes of Treating Patients with Refractory Angina with the Coronary Sinus Reducer: One-Year Outcomes from the REDUCER I Registry.” Join the session to explore sex-specific findings on how the #ShockwaveReducer impacts angina class and quality of life in both female and male patients with refractory angina. 📍 TCT 2025 – Station 5 | Halls B-C | Exhibition Level 🗓️ Sunday OCT 26th 15:00 – 16:00PM Important Safety Inofrmation: http://bit.ly/3iEq7fC  Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.

Achtung – Shockwave IVL Workshop! Erfahren Sie mehr zu innovativen Ansätzen zur Entschlüsselung des „BTK-Codes“ für Kalziumtherapien mit #ShockwaveIVL! Neugierig geworden? Gleich anmelden und Platz sichern! 📅 Freitag, 24. Oct., 10:00-11:00 📍 Clubraum 4, Dreiländertagung, KKL Luzern Important Safety Information: http://bit.ly/3iEq7fC Die Referenten sind bezahlte Berater von Shockwave Medical.

What’s next for #ShockwaveMedical? Our CMO Dr. Nick West had the pleasure of speaking with DeviceTalks West’s Tom Salemi about the waves we’re making in complex cardiovascular disease treatment. From the #COSIRAII trial to new #ShockwaveIVL devices, our unparalleled commitment to energizing innovation and improving patient outcomes stretches far into the future. IVL: US Rx Only. Important Safety Information:  http://bit.ly/3iEq7fC  COSIRA II: Important Safety Information:  http://bit.ly/3iEq7fC  Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use.

#COSIRAII — a multicenter, randomized, sham-controlled trial designed to evaluate a novel therapeutic option for treating refractory angina — is now enrolling patients across the US! Learn more about this transformative technology and trial by visiting the #ShockwaveMedical booth at #TCT2025. Learn more and come see us at TCT Conference: https://lnkd.in/g8rzyZ5T ISI http://bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use.

Another great edition of the Calcium Lab has come to an end! This week, we had the pleasure of welcoming to Verona 25 participants from around the world for an in-depth workshop dedicated to the role of #ShockwaveIVL in the treatment of calcified PAD. A heartfelt thank you to our exceptional faculty — Dr. Stefano Fazzini, Dr. Giacomo Isernia, and Dr. Luca Garriboli — for sharing their expertise and guiding the discussions throughout the course. We look forward to the next Calcium Lab and to continuing to share knowledge and best practices with physicians globally. Interested in joining a future session? Contact your local Shockwave representative for upcoming course dates. US Rx only. Important Safety Information: http://bit.ly/3iEq7fC

Read the first published case of Pedal Loop Angioplasty using #ShockwaveIVL. Instead of atherectomy, Dr. Shadi Halabi, MD, MPH, RPVI, FACC, FSCAI used #ShockwaveE8 to modify the severely calcified vessel due to #ShockwaveIVL’s proven safety profile. Read his JACC Journals paper now:  https://lnkd.in/geabCX2u Learn more about Shockwave IVL’s clinical safety and effectiveness:  https://lnkd.in/gdeVh5HB US Rx only. Important Safety Information: http://bit.ly/3iEq7fC 

Millions of patients with angina struggle with daily discomfort and limited treatment options. Many of them suffer from a severe and chronic form of angina called refractory angina that persists despite optimal medical therapy and procedures such as angioplasty and bypass surgery. But there is hope. International Physicians: Shockwave Reducer is a minimally invasive device designed to redistribute blood flow to the heart, offering relief to patients who have exhausted other treatment options. Learn how #ShockwaveReducer is transforming the lives of patients suffering from refractory angina:  https://lnkd.in/g4S8_kWH  #MedicalInnovation #HeartCare #AnginaAwareness Shockwave Reducer Important Safety Information:  http://bit.ly/3iEq7fC  Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.

Hear the latest on all things #ShockwaveIVL during our expert-led #TCT2025 symposium. Mark your calendars for Sunday, October 26 at 12:30pm PT to meet the next evolution of #CoronaryIVL, learn more about our unique MOA, and explore the latest safety and efficacy data from our clinical studies as well as EMPOWER CAD and BALI. Get all the details and add it to your calendar now: https://lnkd.in/gnm4xGqa US Rx only. Important Safety Information: http://bit.ly/3iEq7fC

We’re proud to celebrate one million patients treated worldwide. Thank you for helping us spark change with #ShockwaveIVL. #TeamworkMakestheTreatmentWork